Arch Guillotti
Senior Member
Staff member
Administrator
Volunteer Staff
Lifetime Donor
20+ Year Member
Advertisement - Members don't see this ad
If anyone has actually read the French study on hydroxychloroquine and azithromycin, you wound see there are major holes in it.
It was not randomized or blinded.
Only 36 patients, 20 in the hydroxychloroquine group and 16 in the control group.
Their graphs of miraculous negative pcrs in the experimental group fail to mention that there were an additional 6 pts initially in the hydroxychloroquine group, 3 who transfered to the ICU, 1 who died who tested negative for pcr the day before death. These were excluded from their outcomes.
No patients in the control group died or went to the icu.
They don't mention whether patents were matched for comorbidities or have s deranged exhausts of patent status at day 0
Don't include all cause mortality at day 14-21. Important as everything we've read states most who die, do so in two to three weeks minimum.
Only include viral load at day six.
Mortality in the control group could very well be better than in the experimental group regardlesss of viral load.
This is why it's irresponsible for our president to be announcing the use of this drug so prematurely to the whole world.
uh yeah, but Blade said it worked😵